Changing molecular epidemiology of group B streptococcus in Korea

Journal of Korean Medical Science

Volumn 25, Issue 6, 2010, Pages 817-823

  Seo, Yong Soo ^a   Srinivasan, Usha ^b   Oh, Kwan Young ^c   Shin, Jung Hwan ^a   Chae, Jeong Don ^a   Kim, Moon Young ^d   Yang, Jae Hyug ^d   Yoon, Hye Ryung ^e   Miller, Brady ^b   DeBusscher, Joan ^b   Foxman, Betsy ^b   Ki, Moran ^f  

^a Eulji General Hospital   (South Korea)

^b UNIVERSITY OF MICHIGAN   (United States)

^c Eulji University   (South Korea)

^d Kwandong University College of Medicine   (South Korea)

^e Seoul Medical Science Institute   (South Korea)

^f Eulji University School of Medicine   (South Korea)

Author keywords

Drug resistance; Genotype; Microbial; Pregnant women; Serotyping; Streptococcus agalactiae

Indexed keywords

ANTIINFECTIVE AGENT; CLINDAMYCIN; ERYTHROMYCIN;

ADULT; ARTICLE; DRUG EFFECT; FEMALE; GENETICS; GENOTYPE; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; MULTIDRUG RESISTANCE; PREGNANCY; PREGNANCY COMPLICATION; SEROTYPING; SOUTH KOREA; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION;

ADULT; ANTI-BACTERIAL AGENTS; CLINDAMYCIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ERYTHROMYCIN; FEMALE; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; REPUBLIC OF KOREA; SEROTYPING; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

EID: 77956408989     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2010.25.6.817     Document Type: Article

References (29)

1. Fry RM. Fatal infections by haemolytic streptococcus group B. Lancet 1933; 1: 199-201.
2. Baker CJ, Barrett FF, Gordon RC, Yow MD. Suppurative meningitis due to streptococci of Lancefield group B: a study of 33 infants. J Pediatr 1973; 82: 724-9.
3. Farley MM, Harvey RC, Stull T, Smith JD, Schuchat A, Wenger JD, Stephens DS. A population-based assessment of invasive disease due to group B streptococcus in nonpregnant adults. N Engl J Med 1993; 328: 1807-11.
4. Phares CR, Lynfield R, Farley MM, Mohle-Boetani J, Harrison LH, Petit S, Craig AS, Schaffner W, Zansky SM, Gershman K, Stefonek KR, Albanese BA, Zell ER, Schuchat A, Schrag SJ. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA 2008; 299: 2056-65.
5. Maione D, Margarit I, Rinaudo CD, Masignani V, Mora M, Scarselli M, Tettelin H, Brettoni C, Iacobini ET, Rosini R, D'Agostino N, Miorin L, Buccato S, Mariani M, Galli G, Nogarotto R, Nardi Dei V, Vegni F, Fraser C, Mancuso G, Teti G, Madoff LC, Paoletti LC, Rappuoli R, Kasper DL, Telford JL, Grandi G. Identification of a universal Group B streptococcus vaccine by multiple genome screen. Science 2005; 309: 148-50.
6. Slotved HC, Kong F, Lambertsen L, Sauer S, Gilbert GL. Serotype IX, a proposed new Streptococcus agalactiae serotype. J Clin Microbiol 2007; 45: 2929-36.
7. Lee HJ, Cho HK, Kim KH, Oh SH, Cha SH, Hur JK. Invasive bacterial infection in immunocompetent children in Korea: a retrospective multicenter study. 5th World Congress of the World Society for Pediatric Infectious Diseases-WSPID. Bangkok, Thailand, 2007; 112.
8. Gygax SE, Schuyler JA, Kimmel LE, Trama JP, Mordechai E, Adelson ME. Erythromycin and clindamycin resistance in group B streptococcal clinical isolates. Antimicrob Agents Chemother 2006; 50: 1875-7.
9. Brimil N, Barthell E, Heindrichs U, Kuhn M, Lutticken R, Spellerberg B. Epidemiology of Streptococcus agalactiae colonization in Germany. Int J Med Microbiol 2006; 296: 39-44.
10. Schrag SJ, Whitney CG, Schuchat A. Neonatal group B streptococcal disease: how infection control teams can contribute to prevention efforts. Infect Control Hosp Epidemiol 2000; 21: 473-83.
11. Lee BK, Song YR, Kim MY, Yang JH, Shin JH, Seo YS, Oh KY, Yoon HR, Pai SY, Foxman B, Ki M. Epidemiology of group B streptococcus in Korean pregnant women. Epidemiol Infect 2010; 138:292-8.
12. NCCLS. Performance Standard for Antimicrobial Susceptibility Testing, M100-S12. Table 2H. Wayne, PA, USA: NCCLS; 2002.
13. Borchardt SM, Foxman B, Chaffin DO, Rubens CE, Tallman PA, Manning SD, Baker CJ, Marrs CF. Comparison of DNA dot blot hybridization and lancefield capillary precipitin methods for group B streptococcal capsular typing. J Clin Microbiol 2004; 42: 146-50.
14. Zhang L, Srinivasan U, Marrs CF, Ghosh D, Gilsdorf JR, Foxman B. Library on a slide for bacterial comparative genomics. BMC Microbiol 2004; 4: 12.
15. Harris TO, Shelver DW, Bohnsack JF, Rubens CE. A novel streptococcal surface protease promotes virulence, resistance to opsonophagocytosis, and cleavage of human fibrinogen. J Clin Invest 2003; 111: 61-70.
16. Zhang L, Reddi U, Srinivasan U, Li S, Borchardt SM, Pillai P, Mehta P, Styka AN, Debusscher J, Marrs CF, Foxman B. Combining microarray technology and molecular epidemiology to identify genes associated with invasive group B streptococcus. Interdiscip Perspect Infect Dis 2008; 314762.
17. Marrs CF, Zhang L, Tallman P, Manning SD, Somsel P, Raz P, Colodner R, Jantunen ME, Siitonen A, Saxen H, Foxman B. Variations in 10 putative uropathogen virulence genes among urinary, faecal and peri-urethral Escherichia coli. J Med Microbiol 2002; 51: 138-42.
18. Lee K, Shin JW, Chong Y, Mikamo H. Trends in serotypes and antimicrobial susceptibility of group B streptococci isolated in Korea. J Infect Chemother 2000; 6: 93-7.
19. Uh Y, Kim HY, Jang IH, Hwang GY, Yoon KJ. Correlation of serotypes and genotypes of macrolide-resistant Streptococcus agalactiae. Yonsei Med J 2005; 46: 480-3.
20. Desjardins M, Delgaty KL, Ramotar K, Seetaram C, Toye B. Prevalence and mechanisms of erythromycin resistance in group A and group B streptococcus: implications for reporting susceptibility results. J Clin Microbiol 2004; 42: 5620-3.
21. Schoening TE, Wagner J, Arvand M. Prevalence of erythromycin and clindamycin resistance among Streptococcus agalactiae isolates in Germany. Clin Microbiol Infect 2005; 11: 579-82.
22. Kim MW, Jang HO, Chang DY, Cho JR, Kim YA, Choi HM, Kim SH, Lee JP, Hwang KJ, Kang BH. Group B streptococcal colonization rate in Korean pregnant women. Korean J Obstet Gynecol 2006; 49: 337-44.
23. Leclercq R, Courvalin P. Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification. Antimicrob Agents Chemother 1991; 35: 1267-72.
24. Sutcliffe J, Tait-Kamradt A, Wondrack L. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob Agents Chemother 1996; 40: 1817-24.
25. Kataja J, Huovinen P, Skurnik M, Seppala H. Erythromycin resistance genes in group A streptococci in Finland. The Finnish Study Group for Antimicrobial Resistance. Antimicrob Agents Chemother 1999; 43: 48-52.
26. de Azavedo JC, McGavin M, Duncan C, Low DE, McGeer A. Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada. Antimicrob Agents Chemother 2001; 45: 3504-8.
27. Hsueh PR, Teng LJ, Lee LN, Ho SW, Yang PC, Luh KT. High incidence of erythromycin resistance among clinical isolates of Streptococcus agalactiae in Taiwan. Antimicrob Agents Chemother 2001; 45: 3205-8.
28. Bozdogan B, Berrezouga L, Kuo M-S, Yurek DA, Farley KA, Stockman BJ, Leclercq R. A new resistance gene, linB, conferring resistance to lincosamides by nucleotidylation in enterococcus faecium HM1025. Antimicrob Agents Chemother 1999; 43: 925-9.
29. Varaldo PE, Montanari MP, Giovanetti E. Genetic elements responsible for erythromycin resistance in streptococci. Antimicrob Agents Chemother 2009; 53: 343-53.